 CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2022 GLOBE NEWSWIRE -- Centogene N.V. Nasdaq: CNTG, the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its investment and partnering conference schedule for September 2022. Company management will present at the H.C. Wainwright 24th Annual Global Investment Conference in New York and the 9th Annual HealthTech Investment Forum HTIF as part of Sachs Autumn Life Sciences Week in Basel. CENTOGENE invites investors and partners to attend the presentations and schedule one-on-one meetings. 